Bristol Myers Squibb Farm.Port, SA secures contract for Antineoplastic and immunomodulating agents - 2023/0491-IPILIMUMAB [5 MG/ML; 10 ML; CONC P/ SOL P/ PERF; FRS] (I1006)

Portugal, June 11 -- Portugal based Bristol Myers Squibb Farm.Port, SA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491-IPILIMUMAB [5 MG/ML; 10 ML; CONC P/ SOL P/ PERF; FRS] (I1006). The value of the contract is worth 74769674 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....